Feasibility study of novel nanoparticles derived from Glycyrrhizae radix as vaccine adjuvant for cancer immunotherapy

Immunotherapy, Ahead of Print.

Source: Immunotherapy - January 4, 2023 Category: Allergy & Immunology Authors: Yuno Suzuki Lisa Munakata Daiki Omata Keiichi Koizumi Ryo Suzuki Source Type: research